Pamoic acid
Names | |
---|---|
IUPAC name
4-[(3-Carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid
|
|
Other names
Embonic acid
|
|
Identifiers | |
130-85-8 | |
901319 | |
ChEBI | CHEBI:50186 |
ChEMBL | ChEMBL177880 |
ChemSpider | 8228 |
EC Number | 204-998-0 |
2920 | |
Jmol 3D model | Interactive image Interactive image |
MeSH | Pamoic+acid |
PubChem | 8546 |
RTECS number | QL2180000 |
UNII | 7RRQ8QZ38N |
|
|
|
|
Properties | |
C23H16O6 | |
Molar mass | 388.38 g·mol−1 |
Melting point | ≥300 °C |
log P | 6.169 |
Acidity (pKa) | 2.675 |
Vapor pressure | {{{value}}} |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
Infobox references | |
Pamoic acid, also called embonic acid, is a naphthoic acid derivative. Salts and esters of pamoic acid are known as pamoates or embonates. It can be prepared by the reaction of 2-hydroxy-3-naphthoic acid with formaldehyde.
In pharmacology, the salt form of pamoic acid (pamoate ion) can be used as a counter ion of a drug compound to increase the solubility of the drug in water.[2] The presence of multiple oxygen atoms enables significant hydrogen bonding to occur. Hydrogen bonds facilitate the dissolution of compounds in water.
Pamoic acid has agonist activity for the orphan G protein-coupled receptor GPR35 by which it activates ERK and beta-arrestin2, and causes antinociceptive activity.[3][4] Although (like other drug salts) it has been considered an inactive compound by the FDA, these recent data suggest that its permitted uses may need to be reexamined.[citation needed]
References
- ↑ Merck Index, 12th Edition, 7136.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.